Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 2/20 | 0.73 |
| ▸ | F2 | P00734 | 1/20 | 0.73 |
| ▸ | F10 | P00742 | 1/20 | 0.73 |
| ▸ | PLAT | P00750 | 1/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 4/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | EGFR | P00533 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.66 |
| ▸ | LCK | P06239 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dibromsalan SCHEMBL29496335 | 1.00 | PLAU (0.73) | PLAUF2F10PLATALOX15 | |
| Dibromsalan SCHEMBL29211119 | 0.94 | PLAU (0.66) | PLAUF2F10PLATALOX15 | |
| Bromochlorosalicylanilide SCHEMBL152257 | 0.90 | P2RX1 (0.77) | PLAUF2F10PLATALOX15 | |
| SCHEMBL330113 | 0.90 | TMPRSS4 (0.67) | PLAUF2F10PLATALOX15 | |
| SCHEMBL19024613 | 0.90 | PLAU (0.61) | PLAUF2F10PLATALOX15 | |
| SCHEMBL30343477 | 0.90 | TMPRSS4 (0.67) | PLAUF2F10PLATALOX15 | |
| Tribromsalan SCHEMBL11242287 | 0.89 | MAPT (0.86) | PLAUF2F10PLATALOX15 | |
| SCHEMBL1628928 | 0.87 | PLAU (0.62) | PLAUF2F10PLATALOX15 | |
| SCHEMBL11683279 | 0.87 | P2RX1 (0.82) | TMPRSS4ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL11683814 | 0.87 | PLAU (0.58) | PLAUF2F10PLATALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | claimed |
| WO-2024064209-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| US-20230323279-A1 | MUTANT ALGAE, METHOD OF PREPARATION AND APPLICATION THEREOF | RELIANCE INDUSTRIES LIMITED (IN) | 2023-10-12 | — | — | US | claimed |
| US-20220000813-A1 | Therapeutic Agent For Phosphodiesterase Inhibition And Its Related Disorders | NOVALEAD PHARMA INC (US) | 2022-01-06 | — | — | US | claimed |
| EP-3927334-A1 | NONHORMONAL UNISEX CONTRACEPTIVES | The Regents of The University of California (US) | 2021-12-29 | — | — | EP | claimed |
| US-20210369652-A1 | Nonhormonal Unisex Contraceptives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-02 | — | — | US | claimed |
| US-11147779-B2 | Therapeutic agent for phosphodiesterase inhibition and its related disorders | Deshpande, Supreet K. (US) | 2021-10-19 | — | — | US | claimed |
| CN-107809908-B | Aqueous antimicrobial film-forming composition for teat treatment by spray application | 艺康美国股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| EP-3263145-B1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON DICKINSON CO (US) | 2021-01-20 | — | — | EP | claimed |
| US-20200038350-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | DUKE UNIVERSITY | 2020-02-06 | — | — | US | claimed |
| WO-1999007382-A1 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-18 | — | — | WO | claimed |
| EP-0710105-A4 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | UNIV AUSTRALIAN (AU) | 1998-06-10 | — | — | EP | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| EP-0710105-A1 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1996-05-08 | — | — | EP | claimed |
| WO-1994028887-A1 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1994-12-22 | — | — | WO | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| US-4323466-A | Germicide | LEVER BROTHERS COMPANY (US) | 1982-04-06 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4173632-A | Fasciolicidal compositions | E. R. SQUIBB & SONS, INC. (US) | 1979-11-06 | — | — | US | claimed |
| US-3956510-A | NESTING, CYLINDERS, LOOPS | BEALL NELSON J | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11147779-B2 | Therapeutic agent for phosphodiesterase inhibition and its related disorders | PDE9A, PDE3A, PDE12 | PLAU 1479/4885F2 1247/4885F10 1903/4885 |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | AHCY, MACO1, ME3 | PLAU 1914/4885F2 4310/4885F10 3869/4885 |
| US-20200038350-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | SFRP1, FZD7, WNT1 | PLAU 2354/4885F2 2158/4885F10 3597/4885 |
| US-20210369652-A1 | Nonhormonal Unisex Contraceptives | UQCRC1, UQCRC2, MCU | PLAU 4201/4885F2 1074/4885F10 981/4885 |
| US-20230323279-A1 | MUTANT ALGAE, METHOD OF PREPARATION AND APPLICATION THEREOF | STOM, PPA1, ALAD | PLAU 4630/4885F2 4616/4885F10 4209/4885 |
| US-20220000813-A1 | Therapeutic Agent For Phosphodiesterase Inhibition And Its Related Disorders | PDE3A, PDE9A, PDE12 | PLAU 1446/4885F2 1258/4885F10 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.